Arena Investors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Arena Investors’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,936	Closed	-$112K	–	79
2023 Q1	$112K	Sell	16,936 -38,264	-69%	-$323K	0.09%	42
2022 Q4	$574K	Hold	55,200	–	–	0.53%	33
2022 Q3	$562K	Hold	55,200	–	–	0.26%	67
2022 Q2	$560K	Hold	55,200	–	–	0.25%	66
2022 Q1	$556K	Buy	+55,200	New	+$554K	0.37%	51

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Arena Investors's OCEA Position: Q2 2023 in Review

Arena Investors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2023, closing a stake of 16,936 shares — an estimated $112K sold.

Arena Investors first reported a position in OCEA in Q1 2022 and held it in 5 quarters. The position peaked at $574K in Q4 2022. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2023.

Arena Investors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Arena Investors sold 16,936 Ocean Biomedical, Inc. Common Stock shares in Q2 2023, an estimated $112K.
Arena Investors first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Arena Investors's Ocean Biomedical, Inc. Common Stock position peaked at $574K in Q4 2022.
35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2023.

Based on Arena Investors's 13F filing for Q2 2023, filed 14 Aug 2023.